Jonathan Grim

2.7k total citations · 2 hit papers
9 papers, 2.1k citations indexed

About

Jonathan Grim is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jonathan Grim has authored 9 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jonathan Grim's work include Ubiquitin and proteasome pathways (3 papers), Acute Myeloid Leukemia Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Jonathan Grim is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Acute Myeloid Leukemia Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Jonathan Grim collaborates with scholars based in United States, Taiwan and Austria. Jonathan Grim's co-authors include Bruce E. Clurman, Markus Welcker, Amir Orian, Robert N. Eisenman, J. Wade Harper, Jianping Jin, James M. Roberts, Jeffrey D. Singer, Keith R. Loeb and Andrew Bloecher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Genes & Development.

In The Last Decade

Jonathan Grim

9 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

2004 756 citations Markus Welcker, Amir Orian et al. Proceedings of the National Academy of Sciences profile →
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors

2007 523 citations Jennifer O’Neil, Jonathan Grim et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Grim United States	8	1.7k	766	331	283	212	9	2.1k
Ichiro Onoyama Japan	23	1.8k 1.0×	885 1.2×	382 1.2×	231 0.8×	329 1.6×	58	2.4k
Bart Lutterbach United States	23	2.5k 1.5×	653 0.9×	207 0.6×	1.0k 3.6×	263 1.2×	29	3.1k
Silvia Grisendi United States	8	1.7k 1.0×	358 0.5×	130 0.4×	597 2.1×	296 1.4×	12	2.1k
J. Nathan Davis United States	20	975 0.6×	375 0.5×	166 0.5×	373 1.3×	109 0.5×	26	1.4k
William Senapedis United States	29	1.6k 0.9×	661 0.9×	128 0.4×	366 1.3×	202 1.0×	79	2.1k
Lauren D. Wood United States	16	1.2k 0.7×	580 0.8×	118 0.4×	240 0.8×	335 1.6×	20	1.7k
Blanca Scheijen Netherlands	24	1.5k 0.9×	615 0.8×	188 0.6×	566 2.0×	259 1.2×	53	2.6k
Jennifer A. Perry United States	14	1.5k 0.9×	471 0.6×	300 0.9×	182 0.6×	140 0.7×	16	1.8k
Steven J. Kuerbitz United States	10	1.8k 1.1×	1.6k 2.0×	159 0.5×	127 0.4×	473 2.2×	19	2.6k
Françoise Cormier France	18	693 0.4×	301 0.4×	202 0.6×	246 0.9×	173 0.8×	32	1.3k

Countries citing papers authored by Jonathan Grim

Since Specialization

Citations

This map shows the geographic impact of Jonathan Grim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Grim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Grim more than expected).

Fields of papers citing papers by Jonathan Grim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Grim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Grim. The network helps show where Jonathan Grim may publish in the future.

Co-authorship network of co-authors of Jonathan Grim

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Grim. A scholar is included among the top collaborators of Jonathan Grim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Grim. Jonathan Grim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tabernero, Josep, Lin Shen, Elena Elimova, et al.. (2022). HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma. Future Oncology. 18(29). 3255–3266. 45 indexed citations

2.

Bateman, Allen, et al.. (2017). Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report. Transplant Infectious Disease. 19(3). 4 indexed citations

3.

Scott, Bart L., Ted Gooley, Mohamed L. Sorror, et al.. (2012). The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation. Blood. 119(11). 2657–2664. 88 indexed citations

4.

O’Neil, Jennifer, Jonathan Grim, Peter R. Strack, et al.. (2007). FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors. The Journal of Experimental Medicine. 204(8). 1813–1824. 523 indexed citations breakdown →

5.

Montgomery, Bruce, Michael Bonham, Peter S. Nelson, et al.. (2005). Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cells. The Prostate. 65(2). 141–150. 27 indexed citations

6.

Welcker, Markus, Amir Orian, Jianping Jin, et al.. (2004). The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proceedings of the National Academy of Sciences. 101(24). 9085–9090. 756 indexed citations breakdown →

7.

Welcker, Markus, Amir Orian, Jonathan Grim, Robert N. Eisenman, & Bruce E. Clurman. (2004). A Nucleolar Isoform of the Fbw7 Ubiquitin Ligase Regulates c-Myc and Cell Size. Current Biology. 14(20). 1852–1857. 257 indexed citations

8.

Grandori, Carla, Kou-Juey Wu, Paula Fernández, et al.. (2003). Werner syndrome protein limits MYC-induced cellular senescence. Genes & Development. 17(13). 1569–1574. 146 indexed citations

9.

Welcker, Markus, Jeffrey D. Singer, Keith R. Loeb, et al.. (2003). Multisite Phosphorylation by Cdk2 and GSK3 Controls Cyclin E Degradation. Molecular Cell. 12(2). 381–392. 302 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact